Fresenius SE
Home
|
Contacts
|
Imprint
|
Sitemap
|
Glossary
|
Guided Tour
|
German
WHO WE ARE
The Health Care Group
Products and Services
Facts and Figures
Locations Worldwide
Management Board
Supervisory Board
Corporate Governance
Business Development / M&A
Environment
History
Frequently Asked Questions
Contacts
INVESTOR RELATIONS
The Fresenius Shares
Credit Relations
News
Financial Reports
Presentations
Directors' Dealings
Outlook, Facts and Figures
Annual General Meeting
Financial Calendar and Conferences
Information & Order Service
Frequently Asked Questions
Contacts
Stock Dictionary
PRESS
Press Releases
Photo Service
Audio/Video Service
TV Service
Calendar
Facts and Figures
Contacts
HEALTHCARE
Fresenius Medical Care
Dialysis at a Clinic or at Home
Hemodialysis
Peritoneal Dialysis
Supplemental Drugs
Other Extracorporeal Systems
Fresenius Kabi
Infusion Therapy
Clinical Nutrition
Home Care
Fresenius Helios
Care Structure
Medical Quality
Knowledge Management
HELIOS Highlights
Fresenius Vamed
Fresenius Biotech
Transplantation
Cancer Therapy
All Segments
CAREER
Why Fresenius?
Who we are looking for
Job Market
Online application
Career Fairs
Personnel in Numbers
Around our Plants
Contacts
SEARCH
Press Releases
All
Business & Finance
2010
2009
2008
2007
2006
2005
2004
2003
2002
Quarterly Results
Medicine & Research
Order Service
Photo Service
Audio/Video Service
TV Service
Calendar
Facts and Figures
Contacts
Share Price
Next Event
02.11.2010
Business development in Q3 2010
>>>
Further events
>>>
To view PDF-files you need Adobe Reader. You can download this software free of charge.
Business & Finance - 2005
20.12.2005
Fresenius Medical Care: Share Conversion Offer Scheduled to Start in January 2006
Text as PDF-file
14.10.2005
Fresenius continues profitable growth
Text as PDF-file
10.10.2005
Legal Actions Taken Against Resolutions of the Extraordinary General Meeting
Text as PDF-file
31.08.2005
Shareholders of Fresenius Medical Care Approve Conversion of Preference Shares into Ordinary Shares and the Transformation of Legal Form into a KGaA
Text as PDF-file
15.08.2005
Extraordinary General Meeting of Fresenius Medical Care AG on August 30, 2005; Voting of Fresenius AG (Press Release of Fresenius Medical Care AG)
Text as PDF-file
15.08.2005
Extraordinary General Meeting of Fresenius Medical Care AG on August 30, 2005 – Voting of Fresenius AG (Press Release of Fresenius AG)
Text as PDF-file
25.07.2005
Gary Brukardt and Key Renal Care Group Executives to Join Fresenius Medical Care upon Closing of the Acquisition
Text as PDF-file
21.07.2005
Fresenius Medical Care Schedules Extraordinary General Meeting for August 30, 2005
Text as PDF-file
01.07.2005
Fresenius Medical Care announces changes of corporate credit rating
Text as PDF-file
01.07.2005
Changes to Fresenius AG’s corporate credit ratings
Text as PDF-file
15.06.2005
Fresenius Medical Care receives second request from U.S. Federal Trade Commission
Text as PDF-file
06.06.2005
Fresenius Medical Care to launch 5008 dialysis machine: improved patients` quality of life and efficient use of resources
Text as PDF-file
04.05.2005
Fresenius Medical Care to Propose Conversion of Preference Shares into Ordinary Shares in Combination with a Change of the Company’s Legal Form into a KGaA
Text as PDF-file
04.05.2005
Fresenius Medical Care to Acquire Renal Care Group, Inc
Text as PDF-file
21.04.2005
Fresenius Medical Care AG acquires Haemotec, Inc., expanding its global manufacturing Base
Text as PDF-file
19.04.2005
Partnership Healthplan of California cooperates with Optimal Renal Care; Launch of New Program to Treat Chronic Kidney Disease Patients
Text as PDF-file
12.04.2005
Fresenius Medical Care Receives 510(k) Clearance for Liberty™ Cycler
Text as PDF-file
06.04.2005
Fresenius Medical Care Announces Receipt of Subpoena
Text as PDF-file
15.03.2005
Fresenius announces changes to the Management Board
Text as PDF-file
02.03.2005
Fresenius Kabi strengthens position in China – increases stake in joint venture from 65 % to 100 %
Text as PDF-file
24.01.2005
Fresenius Medical Care renews long-term Collaborative Agreements with Kawasumi Laboratories in Japan
Text as PDF-file
07.01.2005
Fresenius Kabi continues growth strategy and acquires I.V. drug company
Text as PDF-file
Home
>
Press
>
Press Releases
>
Business & Finance
>
2005